Sanofi Cost Of Sales
Sanofi (SNYNF) reported Cost Of Sales of EUR 13.05 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-02-17
| Period end | Cost Of Sales 6 month | Cost Of Sales 6 month as first filed | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 13.05B EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | 5.88B EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | 13.21B EUR 20-F · filed 2026-02-17 | |||
| 2024-06-30 | 5.97B EUR 6-K · filed 2025-10-27 | 6.85B EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | 12.63B EUR 20-F · filed 2026-02-17 | 14.24B EUR 20-F · filed 2024-02-23 | ||
| 2023-06-30 | 6.35B EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | 11.88B EUR 20-F · filed 2025-02-13 | 13.70B EUR 20-F · filed 2023-02-24 | ||
| 2022-06-30 | 6.13B EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | 12.26B EUR 20-F · filed 2024-02-23 | |||
| 2021-06-30 | 5.54B EUR 6-K · filed 2022-07-28 | 5.54B EUR 6-K · filed 2021-07-29 | ||
| 2020-12-31 | 12.16B EUR 20-F · filed 2023-02-24 | 12.16B EUR 20-F · filed 2021-03-04 | ||
| 2020-06-30 | 5.54B EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | 11.98B EUR 20-F · filed 2022-02-23 | 11.98B EUR 20-F · filed 2020-03-05 | ||
| 2019-06-30 | 5.38B EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | 11.44B EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | 11.61B EUR 20-F · filed 2020-03-05 | 11.61B EUR 20-F/A · filed 2018-03-16 | ||
| 2016-12-31 | 10.70B EUR 20-F · filed 2019-03-08 | 10.70B EUR 20-F/A · filed 2018-03-16 | ||
| 2015-12-31 | 10.92B EUR 20-F/A · filed 2018-03-16 |